» Articles » PMID: 36986508

Hepatic Models to Assess Herb-Drug Interactions: Approaches and Challenges

Overview
Publisher MDPI
Specialty Chemistry
Date 2023 Mar 29
PMID 36986508
Authors
Affiliations
Soon will be listed here.
Abstract

A newfound appreciation for the benefits of herbal treatments has emerged in recent decades. However, herbal medication production still needs to establish standardized protocols that adhere to strict guidelines for quality assurance and risk minimization. Although the therapeutic effects of herbal medicines are extensive, the risk of herb-drug interactions remains a serious concern, limiting their use. Therefore, a robust, well-established liver model that can fully represent the liver tissue is required to study potential herb-drug interactions to ensure herbal medicines' safe and effective use. In light of this, this mini review investigates the existing liver models applicable to detecting herbal medicines' toxicity and other pharmacological targets. This article analyzes the benefits and drawbacks of existing liver cell models. To maintain relevance and effectively express the offered research, a systematic strategy was employed to search for and include all discussed studies. In brief, from 1985 to December 2022, the phrases "liver models", "herb-drug interaction", "herbal medicine", "cytochrome P450", "drug transporters pharmacokinetics", and "pharmacodynamics" were combined to search the electronic databases PubMed, ScienceDirect, and the Cochrane Library.

Citing Articles

In Silico and Chromatographic Methods for Analysis of Biotransformation of Prospective Neuroprotective Pyrrole-Based Hydrazone in Isolated Rat Hepatocytes.

Mateeva A, Kondeva-Burdina M, Mateev E, Nedialkov P, Lyubomirova K, Peikova L Molecules. 2024; 29(7).

PMID: 38611754 PMC: 11013089. DOI: 10.3390/molecules29071474.


Bioactive Properties, Bioavailability Profiles, and Clinical Evidence of the Potential Benefits of Black Pepper () and Red Pepper () against Diverse Metabolic Complications.

Dludla P, Cirilli I, Marcheggiani F, Silvestri S, Orlando P, Muvhulawa N Molecules. 2023; 28(18).

PMID: 37764345 PMC: 10534530. DOI: 10.3390/molecules28186569.

References
1.
Yang Y . Use of herbal drugs to treat COVID-19 should be with caution. Lancet. 2020; 395(10238):1689-1690. PMC: 7228688. DOI: 10.1016/S0140-6736(20)31143-0. View

2.
Moradi E, Jalili-Firoozinezhad S, Solati-Hashjin M . Microfluidic organ-on-a-chip models of human liver tissue. Acta Biomater. 2020; 116:67-83. DOI: 10.1016/j.actbio.2020.08.041. View

3.
Polidoro M, Ferrari E, Marzorati S, Lleo A, Rasponi M . Experimental liver models: From cell culture techniques to microfluidic organs-on-chip. Liver Int. 2021; 41(8):1744-1761. DOI: 10.1111/liv.14942. View

4.
Dewyse L, Reynaert H, van Grunsven L . Best Practices and Progress in Precision-Cut Liver Slice Cultures. Int J Mol Sci. 2021; 22(13). PMC: 8267882. DOI: 10.3390/ijms22137137. View

5.
Messelmani T, Morisseau L, Sakai Y, Legallais C, Le Goff A, Leclerc E . Liver organ-on-chip models for toxicity studies and risk assessment. Lab Chip. 2022; 22(13):2423-2450. DOI: 10.1039/d2lc00307d. View